cyproterone acetate has been researched along with Hepatitis C in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|
1 other study(ies) available for cyproterone acetate and Hepatitis C
| Article | Year |
|---|---|
Oral contraceptives and liver cancer. Results of the Multicentre International Liver Tumor Study (MILTS).
Topics: Adult; Age Factors; Carcinoma, Hepatocellular; Case-Control Studies; Contraceptives, Oral; Cyproterone Acetate; Female; Hepatitis B; Hepatitis C; Humans; Liver Cirrhosis; Liver Neoplasms; Middle Aged; Odds Ratio; Risk Factors; Time Factors | 1997 |